Oxford Immunotec Global PLC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Cash flows from operating activities
Net income (loss)
Less: Net income (loss) from discontinued operations, net of tax
Net income (loss) from continuing operations
Adjustments to reconcile net income (loss) from continuing operations to net cash used in operating activities:
Depreciation and amortization of intangible assets
Change in fair value of contingent purchase price consideration
Write-off of contingent purchase price consideration
Non-cash rent expense
Non-cash interest
Intangible assets impairment charges
Accretion and amortization of loan fees
Share-based compensation expense
Loss on disposal of property and equipment
Deferred income taxes

Changes in operating assets and liabilities:
Accounts receivable, net
Inventory, net
Prepaid expenses and other assets
Accounts payable
Accrued liabilities
Settlement liability
Other liabilities, net
Deferred income
Net cash used in operating activities
Net cash used in operating activities from continuing operations
Cash flows from investing activities
Purchases of property and equipment
Purchases of intangible assets
Cash paid for acquisitions, net of cash acquired
Proceeds on sales of property and equipment
Change in restricted cash
Net cash used in investing activities
Net cash used in investing activities from continuing operations

Cash flows from financing activities
Proceeds from issuance of ordinary shares
Proceeds from exercise of share options
Payments of tax withheld on vesting of restricted share units
Repurchases of ordinary shares
Payments on capital lease
Proceeds from term loan, net
Discount on the line of credit
Debt issuance costs
Loss on extinguishment of debt
Change in loans payable
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents, excluding restricted cash
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Net cash used in financing activities from continuing operations
Net cash flows of continuing operations

Cash flows from discontinued operations
Net operating cash flows provided by discontinued operations
Net investing cash flows provided by discontinued operations
Net financing cash flows used in discontinued operations
Net cash flows of discontinued operations
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Supplemental disclosures
Cash paid for interest
Cash received (paid) for interest
Cash paid for taxes

Comments